Why NeuroMetrix Inc. (NASDAQ: NURO) Is Worth A Spot On Your Watchlist – Marketing Sentinel
Home  »  Business   »  Why NeuroMetrix Inc. (NASDAQ: NURO) Is Worth A Spo...

Why NeuroMetrix Inc. (NASDAQ: NURO) Is Worth A Spot On Your Watchlist

NeuroMetrix Inc. (NASDAQ:NURO)’s traded shares stood at 4.45 million during the latest session, with the company’s beta value hitting 3.08. At the last check today, the stock’s price was $9.75, to imply an increase of 13.14% or $1.13 in intraday trading. The NURO share’s 52-week high remains $38.75, putting it -297.44% down since that peak but still an impressive 84.92% since price per share fell to its 52-week low of $1.47. The company has a valuation of $50.08M, with average of 10.38 million shares over the past 3 months.

Analysts have given a consensus recommendation of a Buy for NeuroMetrix Inc. (NURO), translating to a mean rating of 2.00. Of 1 analyst(s) looking at the stock, 0 analyst(s) give NURO a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 1 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at $0.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored

NeuroMetrix Inc. (NASDAQ:NURO) trade information

After registering a 13.14% upside in the latest session, NeuroMetrix Inc. (NURO) has traded red over the past five days. The stock hit a weekly high of 10.21 this Wednesday, 10/06/21, jumping 13.14% in its intraday price action. The 5-day price performance for the stock is -16.63%, and -21.57% over 30 days. With these gigs, the year-to-date price performance is 172.78%.

Analysts on Wall Street suggest a consensus price target of $50.00, implying an increase of 80.5% to the stock’s recent value. The extremes give us $50.00 and $50.00 for target low and target high price respectively. As such, NURO has been trading -412.82% off suggested target high and -412.82% from its likely low.

NeuroMetrix Inc. (NURO) estimates and forecasts

An assessment of the company’s 5-year growth patterns shows that annual earnings grew an estimated 74.30% for the past 5-year period. While 2021 is set for a 82.20% return in earnings, projections for the next 5 years are at 15.00% annually.

NURO Dividends

NeuroMetrix Inc. has its next earnings report out between October 20 and October 25. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. NeuroMetrix Inc. has a forward dividend ratio of 0, with the share yield ticking at 0.00% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.

NeuroMetrix Inc. (NASDAQ:NURO)’s Major holders

NeuroMetrix Inc. insiders hold 0.59% of total outstanding shares, with institutional holders owning 16.96% of the shares at 17.06% float percentage. In total, 16.96% institutions holds shares in the company, led by Renaissance Technologies, LLC. As of Jun 29, 2021, the company held over 0.15 million shares (or 2.66% of shares), all amounting to roughly $0.51 million.

The next major institution holding the largest number of shares is Vanguard Group, Inc. (The) with 66234.0 shares, or about 1.18% of shares outstanding. As of the market price on Jun 29, 2021, these shares were worth $0.23 million.

>> 7 Top Picks for the Post-Pandemic Economy <<

We also have Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund as the top two Mutual Funds with the largest holdings of the NeuroMetrix Inc. (NURO) shares. Going by data provided on Jun 29, 2021, Vanguard Extended Market Index Fund holds roughly 66234.0 shares. This is just over 1.18% of the total shares, with a market valuation of $0.23 million. Data from the same date shows that the other fund manager holds a little less at 26657.0, or 0.47% of the shares, all valued at about 0.32 million.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

173226

100% free. stop anytime no spam

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

173226

100% free. stop anytime no spam